Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 181
8
Diseases
50
Unique genes
0.192
Avg. similarity score
Dysphonia
Most-connected disease (4 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Dysphonia
Mitochondrial hepatopathy
Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis
Mitochondrial dna depletion syndrome
perrault syndrome 5
Bulimia
Intermittent explosive disorder
fanconi anemia complementation group i
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Dysphonia | 4 | 4 | 2 |
| Mitochondrial hepatopathy | 4 | 4 | 3 |
| Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis | 4 | 4 | 5 |
| Mitochondrial dna depletion syndrome | 3 | 3 | 29 |
| perrault syndrome 5 | 3 | 3 | 1 |
| Bulimia | 2 | 2 | 20 |
| Intermittent explosive disorder | 2 | 2 | 1 |
| fanconi anemia complementation group i | 2 | 2 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| TWNK | 5 / 8 | Dysphonia, Mitochondrial dna depletion syndrome, Mitochondrial hepatopathy, perrault syndrome 5 and 1 more |
| COMT | 3 / 8 | Bulimia, Dysphonia, Intermittent explosive disorder |
| FANCI | 3 / 8 | fanconi anemia complementation group i, Mitochondrial dna depletion syndrome, Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis |
| POLG | 3 / 8 | Mitochondrial dna depletion syndrome, Mitochondrial hepatopathy, Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis |
| POLGARF | 3 / 8 | Mitochondrial dna depletion syndrome, Mitochondrial hepatopathy, Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Nucleotide metabolism | KEGG | 7 / 85 | 19.8× | 5.41e-8 | 3.82e-6 ✓ sig. |
| Pyrimidine metabolism | KEGG | 5 / 58 | 20.7× | 3.95e-6 | 1.56e-4 ✓ sig. |
| Purine metabolism | KEGG | 5 / 128 | 9.4× | 1.83e-4 | 3.66e-3 ✓ sig. |
| Interconversion of nucleotide di- and triphosphates | Reactome | 3 / 29 | 24.8× | 2.30e-4 | 4.37e-3 ✓ sig. |
| Base excision repair | KEGG | 3 / 44 | 16.4× | 7.97e-4 | 1.15e-2 ✓ sig. |
| Pyrimidine salvage | Reactome | 2 / 11 | 43.7× | 9.12e-4 | 1.27e-2 ✓ sig. |
| Transcriptional activation of mitochondrial biogenesis | Reactome | 3 / 51 | 14.1× | 1.23e-3 | 1.58e-2 ✓ sig. |
| Spinocerebellar ataxia | KEGG | 4 / 144 | 6.7× | 2.98e-3 | 3.06e-2 ✓ sig. |
| Citric acid cycle (TCA cycle) | Reactome | 2 / 22 | 21.8× | 3.72e-3 | 3.59e-2 ✓ sig. |
| Drug metabolism - other enzymes | KEGG | 3 / 81 | 8.9× | 4.61e-3 | 4.15e-2 ✓ sig. |
| Citrate cycle (TCA cycle) | KEGG | 2 / 30 | 16.0× | 6.86e-3 | 5.40e-2 |
| Propanoate metabolism | KEGG | 2 / 32 | 15.0× | 7.78e-3 | 5.86e-2 |
| Regulation of Apoptosis | Reactome | 1 / 2 | 120× | 8.31e-3 | 6.11e-2 |
| Enzymatic degradation of Dopamine by monoamine oxidase | Reactome | 1 / 2 | 120× | 8.31e-3 | 6.11e-2 |
| Enzymatic degradation of dopamine by COMT | Reactome | 1 / 3 | 80.1× | 1.24e-2 | 7.78e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| mitochondrial DNA replication | GO:0006264 | 5 / 11 | 170× | 5.10e-11 | 1.57e-8 ✓ sig. |
| DNA biosynthetic process | GO:0071897 | 4 / 32 | 46.7× | 1.54e-6 | 1.17e-4 ✓ sig. |
| carbohydrate derivative metabolic process | GO:1901135 | 3 / 18 | 62.3× | 1.43e-5 | 6.91e-4 ✓ sig. |
| DNA replication | GO:0006260 | 5 / 131 | 14.3× | 2.58e-5 | 1.09e-3 ✓ sig. |
| succinyl-CoA catabolic process | GO:1901289 | 2 / 6 | 125× | 1.05e-4 | 3.12e-3 ✓ sig. |
| mitochondrial DNA repair | GO:0043504 | 2 / 7 | 107× | 1.46e-4 | 4.01e-3 ✓ sig. |
| DNA-templated DNA replication | GO:0006261 | 3 / 41 | 27.3× | 1.79e-4 | 4.67e-3 ✓ sig. |
| mitochondrial transcription | GO:0006390 | 2 / 8 | 93.4× | 1.94e-4 | 4.95e-3 ✓ sig. |
| GMP metabolic process | GO:0046037 | 2 / 12 | 62.3× | 4.55e-4 | 8.97e-3 ✓ sig. |
| nucleotide biosynthetic process | GO:0009165 | 2 / 14 | 53.4× | 6.25e-4 | 1.12e-2 ✓ sig. |
| base-excision repair, gap-filling | GO:0006287 | 2 / 14 | 53.4× | 6.25e-4 | 1.12e-2 ✓ sig. |
| DNA repair | GO:0006281 | 6 / 420 | 5.3× | 8.56e-4 | 1.36e-2 ✓ sig. |
| cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration | GO:0021813 | 1 / 1 | 374× | 2.68e-3 | 2.65e-2 ✓ sig. |
| catecholamine catabolic process | GO:0042424 | 1 / 1 | 374× | 2.68e-3 | 2.65e-2 ✓ sig. |
| norepinephrine secretion | GO:0048243 | 1 / 1 | 374× | 2.68e-3 | 2.65e-2 ✓ sig. |